1Hamid MS,Reza M.Uptake of riboflavin across the brush border membrane of rat intestine:regulation by dietary vitamin levels.Gastroenterology 1993; 105:1294
2Hamid MS,Thomas YM,Kenneth G.Regulation of riboflavin intestinal uptake by protein kinase A:studies with caco-2 cells.Am J Physiol 1994,267(Gastrointest.liver phisiol 30):G955
3Ferrari SRP,Diamond J.Crypt-villus site of glucose transporter induction by dietary carbohydrate in mouse intestine.Am J Physiol 1992; 262:G1069
4Toyosaki T.Mineshita T.Antioxidant effects of riboflavn in aqueous solution.J Agric Food Chem 189;37(2):286
5Toyosaki T.Mineshita T.Antioxidant effects of protein-bound riboflavin and free riboflavin.J Food Sci 1988;53(6):1851
6Rao PV,Bhat KS.Influence of dietary riboflavin deficiency on lenticular glutathione redox cycle,lipid peroxidation,and free radical scavengers in the rat.J Clin Biochem Nutr 1989;6(3):195
7Mack CP,Hultquist DE,Shlafer M.Myocardial flavin reductase and riboflavin:a potential role in decreasing reoxygenation injury.Biochem Biophys Res Commun 1995;212(1):35
8Horiuchi S,Hirano H,Ono S.Reduced and oxidized glutathione concentrations in the lenses of riboflavin-deficient rats.J Nutr Sci Vitaminol 1984;30(4):401
9Hirano H,et al.Effects of B2-deficiency on lipoperoxide and its scavenging system in the rat lens.Int J Vitam Nutr Res 1983; 53(4):377
10Kotegawa H,Sugiyama M,Haramak N.Protective effects of riboflavin and its derivatives against ischemic reperfused damage of rat heart.Biochem Mol Biol Int 1994; 34(4):685
2Tojo M, Gunji T, Yamaguchi S, et al. A case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (glutarie aciduria typeⅡ ) [J]. No To Hattatsu, 2000, 32 (2) :163-168.
3Gregersen N. Riboflavin-reponsive defects of β-oxidation [J]. Inherit Metab Dis, 1985, 8(1) :65-69.
4Antozzi C, GaravagliaB, Mora M, et al. Late-onset riboflavin-resposive myopathy with combinedmultiple acul coenzyme A dehygrogenase and respiratory chain defiency [ J]. Neurology, 1994, 44(11 ) :2135-2138.
5Vergani L, Barile M, Angelini C, et al. Riboflacin therapy biochemical heterogeneity in two adult lipid storage myopathies [J]. Brain, 1999, 122(Pt12) :2401-2411.
6Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy [ J ]. Lab Clin Med, 1989, 114 (22) :473- 501.
7Refsum H, Ueland PM, Nygard O, et al. Homocysteine and cardiovascular disease [J].Annu Rev Med, 1998, 49 (1) :31-62.
8Hustad S, Ueland PM, Vollset AE, et al. Riboflavin as a determinant of plasma total horaocysteine : effect modification by the methylenetetrahydrofolate reductase C677T polymorphism [J]. Clinical Chemistry, 2000, 46(8) :1065-1071.
9McKinley MC, McNulty H, McPartlin J, et al. Effect of riboflavin supplementation on plasma homocysteine in elderly people with low riboflavin status [J]. Eur J Clin Nutr, 2002, 56 (9) : 850-856.
10Moat SJ, Ashfield-Watt PA, Powers HJ, et al. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype [ J]. Clinical Chemistry, 2003, 49(2) :295-302.
